Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

05 Mar 2017 - 09 Mar 2017
20 Mar 2017 - 23 Mar 2017
12 Apr 2017 - 14 Apr 2017

Cell Imaging System Emphasizes Speed and Sensitivity

By BiotechDaily International staff writers
Posted on 26 Dec 2012
ADVERTISEMENT
SARTORIUS AG
The most recent version of a high-speed cell imaging system designed for both screening and research has now been released to the biotech and life science markets.

The GE Healthcare (Chalfont St. Giles, United Kingdom) IN Cell Analyzer 2200 is a high-speed, flexible, modular imaging system suitable for both investigative microscopy and automated high-content screening of organelles, cells, tissues, and whole organisms.

For screening applications a combination of proprietary optics, a choice of large or standard chip camera, and fast hardware and software autofocus capabilities deliver accurate, high-speed imaging. A bright light source reduces exposure times to further maximize speed without compromising image quality and cell health while the rapid image restoration options allow confocal-like images to be obtained.

A variety of innovative imaging features and a wide range of objectives (2 to 100 times) gives exceptional flexibility for real-time research use. The manual microscope mode allows manipulation of images at full size and resolution, in and out zoom capability, and manual settings adjustments (e.g., filters, objectives, and z-height).

The instrument can image a two-colored 96-well plate assay in about 150 seconds and a one-color 1,536 plate in less than 20 minutes. This speed is possible due to a bright, seven-wavelength solid-state light source and scientific-grade CMOS camera coupled with an optimized stage and efficient, easy-to-use control software. Furthermore, the system is designed to maximize the quantitative accuracy of captured images for any sample type, including image restoration for dim samples.

Related Links:

GE Healthcare



Channels

Drug Discovery

view channel
Image: The experimental drug NGI-1 slows cancer growth by blocking glycosylation of the epidermal growth factor receptor (EGFR), which is shown in the above diagram (Photo courtesy of Wikimedia Commons).

Experimental Drug Slows Lung Cancer Growth by Blocking Protein Glycosylation

An interesting new experimental anti-cancer drug slows growth of certain lung tumor cells by preventing the glycosylation of critical cell surface receptor proteins. Asparagine (N)-linked glycosylation... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.